FDA Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products
“When considering whether to rely on a single multicenter trial, it is critical that the possibility of an incorrect outcome be considered and that all the available data be examined for their potential to either support or undercut reliance on a single multicenter trial”